Stock Yards Bank & Trust’s West Pharmaceutical WST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$383K Sell
1,066
-21
-2% -$6.42K 0.01% 316
2026
Q1
$272K Sell
1,087
-2
-0.2% -$498 0.01% 351
2025
Q4
$300K Sell
1,089
-298
-21% -$81.5K 0.01% 340
2025
Q3
$364K Sell
1,387
-100
-7% -$24.3K 0.01% 313
2025
Q2
$325K Sell
1,487
-6
-0.4% -$1.28K 0.01% 321
2025
Q1
$334K Buy
1,493
+13
+0.9% +$3.58K 0.01% 312
2024
Q4
$485K Hold
1,480
– – 0.02% 266
2024
Q3
$444K Sell
1,480
-300
-17% -$91.9K 0.01% 288
2024
Q2
$586K Hold
1,780
– – 0.02% 257
2024
Q1
$704K Hold
1,780
– – 0.02% 248
2023
Q4
$627K Sell
1,780
-275
-13% -$97.3K 0.02% 252
2023
Q3
$771K Sell
2,055
-15
-0.7% -$5.8K 0.03% 229
2023
Q2
$792K Sell
2,070
-165
-7% -$58.9K 0.03% 234
2023
Q1
$774K Sell
2,235
-440
-16% -$129K 0.03% 239
2022
Q4
$629K Sell
2,675
-16
-0.6% -$3.79K 0.02% 264
2022
Q3
$662K Buy
2,691
+100
+4% +$30.5K 0.03% 256
2022
Q2
$783K Buy
+2,591
New +$843K 0.03% 243

Other funds holding WST

Stock Yards Bank & Trust's WST Position: Q2 2026 in Review

Stock Yards Bank & Trust reduced its West Pharmaceutical (WST) stake by 1.9% in Q2 2026, selling an estimated $6.42K and leaving 1,066 shares worth $383K. The position accounts for 0.01% of the portfolio, ranked #316.

Stock Yards Bank & Trust first reported a position in WST in Q2 2022 and has held it in 17 quarters since. The position peaked at $792K in Q2 2023. 834 funds tracked by Wall St. Rank hold WST as of Q2 2026.

  • Stock Yards Bank & Trust held 1,066 shares of West Pharmaceutical worth $383K as of Q2 2026.
  • Stock Yards Bank & Trust sold 21 West Pharmaceutical shares in Q2 2026, an estimated $6.42K.
  • West Pharmaceutical made up 0.01% of Stock Yards Bank & Trust's portfolio in Q2 2026, its #316 holding.
  • Stock Yards Bank & Trust first reported a position in West Pharmaceutical in Q2 2022 and has held it in 17 quarters since.
  • Stock Yards Bank & Trust's West Pharmaceutical position peaked at $792K in Q2 2023.
  • 834 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2026.

Based on Stock Yards Bank & Trust's 13F filing for Q2 2026, filed 13 Aug 2026.